Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Robin Turpin"'
Autor:
Maja Kuharic, Lisa Sharp, Robin Turpin, Brendan Mulhern, Todd Lee, Chloe Elizabeth Grace Rose, Andrea Monteiro, A. Simon Pickard
Background. The self-perceived burden is a patient-centred construct that refers to the perceived impact of the care recipient’s illness and care needs on the physical, social, emotional, and financial well-being of their caregiver(s). The self-per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60d54bc2901b21f66e8c6bfe8a0f4ff5
https://doi.org/10.21203/rs.3.rs-2423517/v1
https://doi.org/10.21203/rs.3.rs-2423517/v1
Publikováno v:
Journal of managed carespecialty pharmacy. 27(11)
BACKGROUND: The efficacy of intravenous (IV) vedolizumab vs subcutaneous (SC) adalimumab for the treatment of moderately to severely active ulcerative colitis (UC) was assessed in the VARSITY clini...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc302da5b333ca46f6d5d2e15a2f04f
https://pubmed.ncbi.nlm.nih.gov/34714104
https://pubmed.ncbi.nlm.nih.gov/34714104
Autor:
Noa Cleveland, Ninfa Candela, John Carter, Maja Kuharic, Joyce Qian, Lily Tang, Robin Turpin, David Rubin
Publikováno v:
Inflammatory Bowel Diseases. 28:S105-S106
BACKGROUND Pivotal trials in ulcerative colitis (UC) have indicated that earlier intervention with a biologic is associated with greater likelihood of treatment response. However, in real-world clinical practice, patients with newly diagnosed UC are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00159bb95728f29946f521e8794ed78d
https://doi.org/10.1093/ibd/izac015.171
https://doi.org/10.1093/ibd/izac015.171
Publikováno v:
Journal of Crohn's and Colitis. 14:S454-S455
Background Intravenous vedolizumab (VDZ IV) is approved for the treatment of moderately to severely active ulcerative colitis (UC). Subcutaneous VDZ (VDZ SC) was studied in the VISIBLE 1 trial (NCT02611830) and is under review by the US Food and Drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58f0b677a4be954e3cb8ecbde020bfd4
https://doi.org/10.1093/ecco-jcc/jjz203.658
https://doi.org/10.1093/ecco-jcc/jjz203.658
Autor:
Dorothy Hoffman, Tricia Lee Wilkins, Shirley Reitz, Melanie D Whittington, Jeremy Fredell, Paul L. Jeffrey, Jeff Myers, Paul Miner, Joe Vandigo, William Rogers, Collin Conway, Genia Long, Seth S. Martin, Sunil Majethia, Jason Spangler, Donna Moncuso, Barbara Henry, Robin Turpin, Jane Barlow, Louis Tharp, Laura M. Koontz, Cynthia Bens, Stephen George, Ana Stojanovska, Kyle Skiermont, Scott Jauch, Annette Powers, Bill Martin, Tim Brent, Michael Ciarametaro, Bonnie Shaul, Susan Trieu, Pamela Keith, Matthew Harman
Publikováno v:
Journal of managed carespecialty pharmacy. 25(2)
High-investment medications, such as gene therapy and innovative specialty medications, offer breakthrough treatments that can greatly improve outcomes to patients with serious health conditions. However, many of these therapies are associated with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd59f51adc43e0a7a6783e67ac42253
https://pubmed.ncbi.nlm.nih.gov/30698091
https://pubmed.ncbi.nlm.nih.gov/30698091
Publikováno v:
Gastroenterology. 158:S-658
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ee8f22e1651f417dd9bee1c1f99d3e
https://doi.org/10.1016/s0016-5085(20)32341-6
https://doi.org/10.1016/s0016-5085(20)32341-6
Publikováno v:
Journal of Crohn's and Colitis. 14:S508-S508
Background VARSITY (NCT02497469) is the first head-to-head trial comparing two biologic therapies, intravenous vedolizumab (VDZ IV) and subcutaneous adalimumab (ADA), in adults with moderately to severely active ulcerative colitis (UC). We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c461a9eefde19094fa9e6c9df57304f2
https://doi.org/10.1093/ecco-jcc/jjz203.735
https://doi.org/10.1093/ecco-jcc/jjz203.735
Publikováno v:
Annals of the Rheumatic Diseases. 75:374.1-374
Background Chronic management of hyperuricemia with xanthine oxidase inhibitors has been shown to reduce long term incidence of gout flares, but their resultant impact in highly comorbid populations is unclear. Objectives To compare major cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d80540b0ef0ec0b96303bc851bf7186
https://doi.org/10.1136/annrheumdis-2016-eular.3029
https://doi.org/10.1136/annrheumdis-2016-eular.3029
Autor:
Lawrence R. Kosinski, Michael Sørensen, Pamela Landsman, Robin Turpin, Charles Baum, Joel V. Brill
Publikováno v:
Gastroenterology. 150:S173
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2695bb33ee2b62e1e24214ae1f693825
https://doi.org/10.1016/s0016-5085(16)30668-0
https://doi.org/10.1016/s0016-5085(16)30668-0
Publikováno v:
The Journal of Spinal Cord Medicine. 18:9-13
Spinal cord injury (SCI) patients experience varying degrees of wrist and shoulder pain. Previous studies indicated that 30 to 64 percent of SCI patients reported chronic shoulder pain. The purpose of this study was to identify the prevalence of chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b67108fda7645ec208fed66d77d80a
https://doi.org/10.1080/10790268.1995.11719374
https://doi.org/10.1080/10790268.1995.11719374